The PCR Technologies Market is expected to be around US$ 11.70 Billion by 2028 at a CAGR of 6% in the given forecast period.
Rise in the elderly population, significant prevalence of infectious diseases, increase in number of diagnostic centers and hospitals, and rise in awareness and acceptance of personalized medicine propels the polymerase chain reaction technologies market size. Furthermore, the advancement in the technology of qPCR and dPCR leading to automation, enhanced accuracy, and improved sensitivity crucially drive the market growth. These products offer excellent of efficiency and productivity in R&D discovery and minimize the time needed for the new drug development. Moreover, there is high demand for polymerase chain reaction technologies due to increase in number of hospitals and research centers. Furthermore, the increased number of patients suffering from infectious diseases will also help to fuel the growth of the global polymerase chain reaction technologies market.
The global PCR Technologies market is segregated on the basis of Technology as Real-Time PCR, Traditional PCR and Digital PCR. Based on Product the global PCR Technologies market is segmented in Reagents & Consumables, Instruments, Software and Services. Based on Application the global PCR Technologies market is segmented in Clinical, Research and Forensics.
Based on End Users, the global PCR Technologies market is segmented in Diagnostic Centers & Hospitals, Biotech & Pharma Companies and Academic & Research Institutions.
The global PCR Technologies market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The PCR Technologies market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Thermo Fisher Scientific Inc., Sygnis AG, LGC Ltd., Bio-Rad Laboratories Inc., Agilent Technologies, Inc., BioMerieux S.A., RainDance Technologies, Inc., Affymetrix Inc., Fluidigm Corporation, Takara Bio Inc., GE Healthcare, Kapa Biosystems, Maxim Biotech, PerkinElmer, Promega, and others are among the major players in the global PCR Technologies market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The PCR Technologies Market has been segmented as below:
PCR Technologies Market, By Technology
PCR Technologies Market, By Product
PCR Technologies Market, By Application
PCR Technologies Market, By End Users
PCR Technologies Market, By Region
PCR Technologies Market, By Company
The report covers:
Report Scope:
The global PCR Technologies market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global PCR Technologies market share. Major industry players with significant revenue share include Thermo Fisher Scientific Inc., Sygnis AG, LGC Ltd., Bio-Rad Laboratories Inc., Agilent Technologies, Inc., BioMerieux S.A., RainDance Technologies, Inc., Affymetrix Inc., Fluidigm Corporation, Takara Bio Inc., GE Healthcare, Kapa Biosystems, Maxim Biotech, PerkinElmer, Promega, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our new Reports :-
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1.1. Secondary Research
2.3.1.2. Primary Research
2.3.1.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach- Segmental Market Analysis
2.4.2. Top-Down Approach- Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Porter’s Five Force Analysis
5. PCR Technologies Market, By Technology
5.1. Introduction
5.2. Real-Time PCR
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.3. Traditional PCR
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.4. Digital PCR
5.4.1. Market Overview
5.4.2. Market Size and Forecast
6. PCR Technologies Market, By Product
6.1. Introduction
6.2. Reagents & Consumables
6.2.1. Market Overview
6.2.2. Market Size and Forecast
6.3. Instruments
6.3.1. Market Overview
6.3.2. Market Size and Forecast
6.4. Software
6.4.1. Market Overview
6.4.2. Market Size and Forecast
6.5. Services
6.5.1. Market Overview
6.5.2. Market Size and Forecast
7. PCR Technologies Market, By Application
7.1. Introduction
7.2. Clinical
7.2.1. Market Overview
7.2.2. Market Size and Forecast
7.3. Research
7.3.1. Market Overview
7.3.2. Market Size and Forecast
7.4. Forensics
7.4.1. Market Overview
7.4.2. Market Size and Forecast
8. PCR Technologies Market, By End Users
8.1. Introduction
8.2. Diagnostic Centers & Hospitals
8.2.1. Market Overview
8.2.2. Market Size and Forecast
8.3. Biotech & Pharma Companies
8.3.1. Market Overview
8.3.2. Market Size and Forecast
8.4. Academic & Research Institutions
8.4.1. Market Overview
8.4.2. Market Size and Forecast
9. PCR Technologies Market, By Geography
9.1. Introduction
9.2. North America
9.2.1. North America PCR Technologies, By Technology
9.2.2. North America PCR Technologies, By Product
9.2.3. North America PCR Technologies, By Application
9.2.4. North America PCR Technologies, By End Users
9.3. Europe
9.3.1. Europe PCR Technologies, By Technology
9.3.2. Europe PCR Technologies, By Product
9.3.3. Europe PCR Technologies, By Application
9.3.4. Europe PCR Technologies, By End Users
9.4. Asia-Pacific
9.4.1. Asia-Pacific PCR Technologies, By Technology
9.4.2. Asia-Pacific PCR Technologies, By Product
9.4.3. Asia-Pacific PCR Technologies, By Application
9.4.4. Asia-Pacific PCR Technologies, By End Users
9.5. Rest of the World
9.5.1. Rest of the World PCR Technologies, By Technology
9.5.2. Rest of the World PCR Technologies, By Product
9.5.3. Rest of the World PCR Technologies, By Application
9.5.4. Rest of the World PCR Technologies, By End Users
10. Competitive Insights
10.1. Key Insights
10.2. Company Market Share Analysis
10.3. Strategic Outlook
10.3.1. Mergers & Acquisitions
10.3.2. New Product Developments
10.3.3. Portfolio/Production Capacity Expansions
10.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5. Others
11. Company Profiles
11.1. Thermo Fisher Scientific Inc.
11.1.1. Company Overview
11.1.2. Product/Service Landscape
11.1.3. Financial Overview
11.1.4. Recent Developments
11.2. Sygnis AG
11.2.1. Company Overview
11.2.2. Product/Service Landscape
11.2.3. Financial Overview
11.2.4. Recent Developments
11.3. LGC Ltd.
11.3.1. Company Overview
11.3.2. Product/Service Landscape
11.3.3. Financial Overview
11.3.4. Recent Developments
11.4. Bio-Rad Laboratories Inc.
11.4.1. Company Overview
11.4.2. Product/Service Landscape
11.4.3. Financial Overview
11.4.4. Recent Developments
11.5. Agilent Technologies, Inc.
11.5.1. Company Overview
11.5.2. Product/Service Landscape
11.5.3. Financial Overview
11.5.4. Recent Developments
11.6. BioMerieux S.A.
11.6.1. Company Overview
11.6.2. Product/Service Landscape
11.6.3. Financial Overview
11.6.4. Recent Developments
11.7. RainDance Technologies, Inc.
11.7.1. Company Overview
11.7.2. Product/Service Landscape
11.7.3. Financial Overview
11.7.4. Recent Developments
11.8. Affymetrix Inc.
11.8.1. Company Overview
11.8.2. Product/Service Landscape
11.8.3. Financial Overview
11.8.4. Recent Developments
11.9. Fluidigm Corporation
11.9.1. Company Overview
11.9.2. Product/Service Landscape
11.9.3. Financial Overview
11.9.4. Recent Developments
11.10. Takara Bio Inc.
11.10.1. Company Overview
11.10.2. Product/Service Landscape
11.10.3. Financial Overview
11.10.4. Recent Developments
11.11. GE Healthcare
11.11.1. Company Overview
11.11.2. Product/Service Landscape
11.11.3. Financial Overview
11.11.4. Recent Developments
11.12. Kapa Biosystems
11.12.1. Company Overview
11.12.2. Product/Service Landscape
11.12.3. Financial Overview
11.12.4. Recent Developments
11.13. Maxim Biotech
11.13.1. Company Overview
11.13.2. Product/Service Landscape
11.13.3. Financial Overview
11.13.4. Recent Developments
11.14. PerkinElmer
11.14.1. Company Overview
11.14.2. Product/Service Landscape
11.14.3. Financial Overview
11.14.4. Recent Developments
11.15. Promega
11.15.1. Company Overview
11.15.2. Product/Service Landscape
11.15.3. Financial Overview
11.15.4. Recent Developments
The PCR Technologies Market has been segmented as below:
PCR Technologies Market, By Technology
PCR Technologies Market, By Product
PCR Technologies Market, By Application
PCR Technologies Market, By End Users
PCR Technologies Market, By Region
PCR Technologies Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
